Bain Capital
http://www.baincapital.comBain Capital, LLC is a global private investment firm that manages several pools of capital including private equity, venture capital, public equity and leveraged debt assets with more than $65 billion in assets under management. Since its inception in 1984, Bain Capital has made private equity investments and add-on acquisitions in more than 300 companies in a variety of industries around the world, and has a team of almost 300 professionals dedicated to investing in and supporting its portfolio companies, including such leading companies as Dunkin' Donuts, Michaels Stores and Domino's Pizza. Headquartered in Boston, Bain Capital has offices in New York, London, Munich, Hong Kong, Shanghai and Tokyo.
View Older Stories
-
Form 13F-NT Bain Capital Life Scienc For: Jun 30
-
Form 13F-NT Bain Capital Life Scienc For: Jun 30
-
Form 13F-NT Bain Capital Life Scienc For: Jun 30
-
Form 13F-NT Bain Capital Life Scienc For: Jun 30
-
Form 13F-NT Bain Capital Life Scienc For: Jun 30
-
Form 13F-NT Bain Capital Partners For: Jun 30
-
Form 13F-NT Bain Capital Life Scienc For: Jun 30
-
Form 13F-NT Bain Capital Venture For: Jun 30
-
Form 13F-NT Bain Capital Life Scienc For: Jun 30
-
Form 13F-NT Bain Capital Venture For: Jun 30
-
Form 13F-NT Bain Capital Venture For: Jun 30
-
Form 13F-NT Bain Capital Life Scienc For: Jun 30
-
Form 13F-NT Bain Capital Venture For: Jun 30
-
Form 13F-NT Bain Capital Venture For: Jun 30
-
Form 13F-HR BAIN CAPITAL VENTURE For: Jun 30
-
Form 13F-HR Bain Capital Life Scienc For: Jun 30
-
Form 13F-NT Bain Capital Life Scienc For: Jun 30
-
Form 13F-NT Bain Capital Partners For: Jun 30
-
Form 13F-HR Bain Capital Prairie, For: Jun 30
-
Form 13F-NT Bain Capital Prairie For: Jun 30
-
Form 13F-NT Bain Capital Prairie For: Jun 30
-
Form 13F-NT Bain Capital Life Scienc For: Jun 30
-
Form SCHEDULE 13G/A Cabaletta Bio, Inc. Filed by: Bain Capital Life Sciences Opportunities III, LP
-
Form SCHEDULE 13G/A Kyverna Therapeutics, Filed by: Bain Capital Life Sciences Opportunities III, LP
-
Form SCHEDULE 13G/A RAPID MICRO BIOSYSTEMS, Filed by: Bain Capital Life Sciences Fund, L.P.
-
Form 13F-HR Bain Capital Public Equi For: Jun 30
-
Form 13F-HR Bain Capital Public Equi For: Jun 30
-
Form 13F-HR Bain Capital Credit, LP For: Jun 30
-
Form 10-Q Bain Capital Private For: Jun 30
-
Form 10-Q Bain Capital GSS Investm For: Jun 30
-
Form SCHEDULE 13G/A Bain Capital Private Filed by: Bain Capital Credit, LP
-
Form SCHEDULE 13G Bain Capital Private Filed by: Bain Capital Private Credit Offshore Access Fund General Partner, LLC
-
Form SCHEDULE 13D/A LINCOLN NATIONAL CORP Filed by: Bain Capital Prairie, LLC
-
Form 8-K Bain Capital Specialty For: Aug 10
-
Form 10-Q Bain Capital Specialty For: Jun 30
-
Hackers targeted US private equity, other firms including Blackstone, CME - Reuters
-
Eightco Holdings reports $378M in total treasury assets
-
Tarsus Pharmaceuticals raises $125M in oversubscribed PIPE financing
-
Form SC TO-I Bain Capital Private Filed by: Bain Capital Private Credit
-
Form SC TO-I/A Bain Capital Private Filed by: Bain Capital Private Credit
-
Form D Bain Capital European
-
Form 497J Lincoln Bain Capital
-
Form D Bain Capital High Income
-
Ares Management closes $8.2B in U.S. direct lending in Q2 2026
-
Form 8-K Bain Capital Specialty For: Jul 28
-
Lincoln Financial strikes reinsurance deal with Talcott for $5.8B
-
Form 424B3 Lincoln Bain Capital
-
Processa acquires Vidya Therapeutics in $200M private placement deal
-
Bain Capital leads $1.5B investment in Eaton Fiber for Verizon expansion
-
Synlogic and Caldera Therapeutics agree to all-stock merger
